No Picture

Welcome CIRM 2.0 and President Mills

May 1, 2014 admin 0

The future is now. Or so goes the expression. For CIRM, it rings true today. Last year I blogged about what we might expect from the new CIRM that would evolve and take form in the future. I was particularly […]

No Picture

New Stem Cell Stock Ticker

December 5, 2013 admin 11

I’ve added a fun and helpful new feature on the right side bar of the blog in the form of a stock ticker for some of the most widely held stem and cellular medicine companies. A sample screen shot is […]

No Picture

Stem Cell & Cell Med Industry Briefs

December 4, 2013 admin 1

Where do things stand with some players in the for-profit world of stem cell and cellular medicine companies? Here are a few brief news items with quick analysis. Mesoblast is dominating the news of late. Mesoblast reported good news from […]

No Picture

Osiris FDA Letter: Trick or Treat?

October 29, 2013 admin 3

Osiris, a cellular therapy biotech, recently received a so-called “untitled letter” from the FDA. The text of the letter seems on the whole negative in my opinion, while the company’s public reaction to the letter on the other hand could […]